New England Capital Financial Advisors LLC Verrica Pharmaceuticals Inc. Transaction History
New England Capital Financial Advisors LLC
- $197 Billion
- Q1 2025
A detailed history of New England Capital Financial Advisors LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 2,000 shares of VRCA stock, worth $15,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$15,900
Previous $1.4 Million
36.79%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VRCA
# of Institutions
73Shares Held
20.3MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY8.57MShares$68.1 Million1.04% of portfolio
-
Boothbay Fund Management, LLC New York, NY2.81MShares$22.3 Million0.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.36MShares$18.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$8.1 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...